Cita APA (7a ed.)

Tian, T., Yu, M., Li, J., Jiang, M., Ma, D., Tang, S., . . . Lu, Y. (2021). Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Tian, Tian, et al. Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Tian, Tian, et al. Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers Media S.A, 2021.